BioTech Medics, Inc., Engages Optininvestors, a Canadian Public Relations Firm
22 November 2005 - 4:35AM
PR Newswire (US)
DALLAS, Nov. 21 /PRNewswire-FirstCall/ -- Keith Houser, CEO of
BioTech Medics, Inc., (OTC Pink Sheets: BTMD) announced that BTMD
signed a contract with Optininvestors. "Optininvestors a
public/investor relations firm has over 15 years experience helping
companies. Optininvestors has an extensive database of 25+ million
investors and money managers, who have a high degree of interest in
small companies," said Mr. Houser. "In one week, Optininvestors has
proven to the Board they can produce and perform." BioTech Medics
has entered into an agreement with a Pennsylvania company that was
introduced by Optininvestors which intends to invest in BTMD's
Pennsylvania 504 Reg D Exempt Offering filed in January 2005.
Originally, Hamilton Holding P.A., with Mr. William Seminario,
President, represented by Adam Barnett (CEO) entered a contract and
executed a $1 million Promissory Note. In May 2005, BTMD declared a
breach of the contract and default on the Promissory Note with less
than $75k paid on the note. Five Million shares were issued to
Hamilton out of 25 million authorized. Hamilton sold over 2.9
million shares prior to the breach/default. "Prior to December 7,
2004, BTMD (formerly CBLH) was a shell corporation with zero income
and assets. Under new directors and management, BTMD has been
successful in securing and creating $5.00 in assets for every 504
dollar raised through highly structured acquisitions," said Keith
Houser, CEO. "BTMD announced in September that BTMD was seeking to
acquire a medical/office building in Dallas, Texas to add to the
company asset base. Negotiations are continuing. The acquisition is
expected to add a few more million dollars to BTMD's balance sheet.
The 504 share sale will allow the company to acquire more assets on
BTMD's books, thus not diluting the stock value. BTMD currently has
over $2.5 million more in assets than in all of its previous 7 year
history and over $700,000 in combined Gross Revenue which is
$650,000 more than the company has previously earned annually
(under Corbel management). The company has millions in unrealized
asset value from proprietary protocols and patent acquisitions this
year, but due to Sarbanes- Oxley the company is restricted to book
the assets at cost." BioTech Medics operates a Pain Management
& Wellness Center in Dallas; is a distributor for the NeuroLase
Therapeutic Medical Laser and sells the patented SHBAN anti-mold,
anti-mildew anti-bacterial Cleaning & Disinfectant Cleaner. The
company plans on 100 or more Pain Management centers nationwide.
Safe Harbor for Forward-Looking Statements. This press release may
contain forward-looking statements within the meaning of The
Private Securities Litigation Reform Act of 1995 (the "Act"). In
Particular, when used, the words "plan," "confident that,"
"believe," "scheduled," "expect," or "intend to," and similar
conditional expressions are intended to identify forward-looking
statements within the meaning of the Act and are subject to the
safe harbor created by the Act. Such statements are subject to
certain risks and uncertainties and actual results could differ
materially from those expressed in any of the forward-looking
statements. Keith Houser, CEO of BioTech Medics, +1-972-274-5533
DATASOURCE: BioTech Medics, Inc. CONTACT: Keith Houser, CEO of
BioTech Medics, Inc., +1-972-274-5533 Web site:
http://www.biotechmedics.com/
Copyright